Endocyte (ECYT) Tops Q3 EPS by 6c

Endocyte (NASDAQ: ECYT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Bank of America lifts tobacco estimates after regulatory wins
• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance